| Literature DB >> 35812645 |
Shin Watanabe1, Masaaki Minagawa2, Tadashi Shinoda3, Daisuke Motooka4, Mari Tohya1, Teruo Kirikae1, Shota Nakamura4, Akio Saiura2.
Abstract
Background Bile inhibits bacterial growth because it is rich in bacteriostatic compounds such as bile acids. Analytical techniques using a high-intensity sequencer recently revealed bacterial flora in the bile of normal gallbladders in brain-dead patients. Therefore, we performed a microbial flora analysis of bile collected from pathologically normal gallbladders surgically removed from patients with hepatobiliary pancreatic diseases and normal liver function. Methods Bacterial DNA was extracted from bile samples and analyzed using 16S rRNA sequencing. Results The culture results of all 12 bile samples were negative. However, the results of the 16S ribosome gene analysis suggested the presence of bacterial flora in all samples. The phyla Firmicutes, Proteobacteria, Actinobacteria, and, more specifically, the genera Anaerobacillus, Delftia, Bacillus, Ralstonia, Ochrobactrum, Acidovorax, and Curvibacter were detected in all 12 samples. The results of the 16S rRNA gene profile analysis revealed that Anaerobacillus and Delftia accounted for 58.62%-87.63% of the bacteria identified in each sample. Conclusion In a bacterial flora analysis targeting the 16S ribosomal gene, a specific bacterial flora was detected in bile collected from the pathologically normal gallbladders of patients with hepatobiliary pancreatic diseases. Although a diverse bacterial flora was previously reported in the bile of brain-dead patients, the present results revealed a simple bacterial flora with no diversity in the bile samples.Entities:
Keywords: bile; gallbladder; human; microbiome; rrna genes
Year: 2022 PMID: 35812645 PMCID: PMC9257430 DOI: 10.7759/cureus.25681
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Clinical characteristics and biochemical data of the study subjects
WBC: white blood cell count, CRP: C-reactive protein, T-bil: total bilirubin, γ-GTP: γ-glutamyl transpeptidase, AST: aspartate aminotransferase, ALT: alanine aminotransferase, CA19-9: carbohydrate antigen 19-9
| Patient No. | Sex | Age | Disease | Surgical procedure | WBC | CRP | T-bil | Γ-GTP | AST | ALT | Lipase | CA19-9 |
| reference ranges for blood tests | ||||||||||||
| M: 3.9-9.7 ×109/L F: 3.6-8.9 ×109/L | <0.30 mg/dL | 0.4-1.2 mg/dL | 0-75 U/L | 5-37 U/L | 6-43 U/L | 14-56 U/L | <37 U/mL | |||||
| 1 | Male | 70 | hepatocellular carcinoma | hepatectomy of segments 5 and 6 | 6.3 | 0.08 | 0.63 | 27 | 39 | 41 | 61 | 1 |
| 2 | Female | 69 | pancreatic neuroendocrine tumor | pancreatoduodenectomy | 6.0 | 0.29 | 1.62 | 23 | 16 | 13 | 33 | 6 |
| 3 | Female | 44 | solid-pseudopapillary neoplasm | pancreatoduodenectomy | 7.8 | 0.04 | 0.47 | 13 | 20 | 15 | 37 | 5 |
| 4 | Male | 71 | pancreatic head cancer | pancreatoduodenectomy | 4.7 | 2.48 | 0.42 | 15 | 25 | 21 | 255 | 10 |
| 5 | Male | 63 | pancreatic body cancer | resection of the pancreatic body and tail | 4.2 | 0.05 | 0.6 | 20 | 16 | 15 | 45 | 1712 |
| 6 | Male | 48 | gastrointestinal stromal tumor | partial duodenectomy | 3.9 | 0.04 | 2.1 | 61 | 30 | 26 | 49 | 4 |
| 7 | Male | 84 | metastatic liver cancer | hepatectomy of segments 4 and 5 | 5.1 | 0.05 | 0.7 | 13 | 16 | 13 | NA | 8 |
| 8 | Male | 70 | pancreatic body cancer | resection of the pancreatic body and tail | 3.7 | 0.17 | 0.58 | 50 | 35 | 37 | 121 | 8 |
| 9 | Male | 70 | pancreatic neuroendocrine tumor | pancreatoduodenectomy | 5.5 | 0.05 | 0.61 | 15 | 20 | 14 | 30 | 24 |
| 10 | Female | 89 | hepatocellular carcinoma | enucleation of the liver | 7.5 | 0.34 | 0.5 | 23 | 18 | 11 | 21 | 6 |
| 11 | Male | 43 | pancreatic body cancer | pancreatoduodenectomy | 5.6 | 0.02 | 1.16 | 30 | 26 | 43 | 12 | 19 |
| 12 | Male | 68 | hepatocellular carcinoma | hepatic anterior segmentectomy | 3.1 | 0.03 | 0.39 | 56 | 24 | 17 | 70 | NA |
Figure 116S ribosomal gene analysis (phylum)
Figure 216S ribosomal gene analysis (genus)